BeOne Medicines (ONC) EBIT Margin Growth (1y) (2016 - 2026)
BeOne Medicines (ONC) EBIT Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,552.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1,276.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 1,997.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,552.00 |
| Dec 31, 2025 | 1,939.00 |
| Sep 30, 2025 | 2,356.00 |
| Jun 30, 2025 | 1,821.00 |
| Mar 31, 2025 | 3,576.00 |
| Dec 31, 2024 | 5,345.00 |
| Sep 30, 2024 | 514.00 |
| Jun 30, 2024 | 4,201.00 |
| Mar 31, 2024 | 4,814.00 |
| Dec 31, 2023 | 6,279.00 |
| Sep 30, 2023 | 9,594.00 |
| Jun 30, 2023 | 7,510.00 |
| Mar 31, 2023 | 6,166.00 |
| Dec 31, 2022 | -21,235.00 |
| Sep 30, 2022 | 11,086.00 |
| Jun 30, 2022 | 18,794.00 |
| Mar 31, 2022 | -15,615.00 |
| Dec 31, 2021 | 57,348.00 |
| Sep 30, 2021 | 25,929.00 |
| Jun 30, 2021 | 23,020.00 |